During the past decade, Klinikum Bielefeld conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 13 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Bielefeld" #1 sponsor was "Biotronik SE & Co. KG" with 6 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Bielefeld" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Biotronik, Inc." with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator, "Evangelisches Krankenhaus Bielefeld gGmbH" with 1 trials as a collaborator and "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Bielefeld" are "Heart Failure" (9 trials), "Atrial Fibrillation" (4 trials), "Tachycardia, Ventricular" (2 trials), "Adenocarcinoma of the Stomach" (1 trials) and "Advanced Gastric or EGJ Cancer" (1 trials). Many other conditions were trialed in "Klinikum Bielefeld" in a lesser frequency.

Most popular intervention types in "Klinikum Bielefeld" are "Drug" (19 trials), "Device" (10 trials), "Procedure" (6 trials), "Other" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (3 trials), "PF-06700841" (2 trials), "Vehicle (Placebo)" (2 trials) and "5-Fluorouracil (TPF) (only until Feb 2009)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Bielefeld" are 36 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Bielefeld". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Klinikum Bielefeld, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Bielefeld, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 8 trials that are defined as “Not Applicable".

Klinikum Bielefeld has several departments that took part in Clinical trials: "Klinikum Bielefeld, Klinik für Hämatologie, Onkologie und Palliativmedizin" - 2 trials